Skip to main content
Top
Published in: BMC Public Health 1/2008

Open Access 01-12-2008 | Research article

Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden

Authors: Lennart Welin, Annika Adlerberth, Kenneth Caidahl, Henry Eriksson, Per-Olof Hansson, Saga Johansson, Annika Rosengren, Kurt Svärdsudd, Catharina Welin, Lars Wilhelmsen

Published in: BMC Public Health | Issue 1/2008

Login to get access

Abstract

Background

Random samples of 50-year-old men living in Gothenburg have been examined every 10th year since 1963 with a focus on cardiovascular risk factors. The aims of the study were to acquire up-to-date information about risk factors in the fifth cohort of 50-year-old men and women, to re-examine those who were 50 years of age in 1993, and to analyse the prevalence of the metabolic syndrome (MetSyn) using different definitions.

Methods

A random sample of men and women born in 1953 were examined in 2003–2004 for cardiovascular risk factors. Men born in 1943 and that participated in the examination in 1993 were also invited. Descriptive statistics were calculated.

Results

The participation rate among men and women born in 1953 was 60 and 67% respectively. Among men born in 1943, the participation rate was 87%. The prevalence of obesity was from 15 to 17% (body mass index, BMI ≥ 30) in the three samples. The prevalence of known diabetes was 4% among the 50-year-old men and 6% among the 60-year-old men, and 2% among the women. Increased fasting plasma glucose varied substantially from 4 to 33% depending on cut-off level and gender. Mean cholesterol was 5.4 to 5.5 mmol/l. Smoking was more common among women aged 50 (26%) than among men aged 50 (22%) and 60 years (15%). The prevalence of the MetSyn varied with the definition used: from 10 to 15.8% among the women, from 16.1 to 26% among 50-year-old men, and from 19.9 to 35% among the 60-year-old men. Only 5% of the men and women had no risk factors.

Conclusion

This study provides up-to-date information about the prevalence of cardiovascular risk factors and the MetSyn in middle-aged Swedish men and women. Different definitions of the MetSyn create confusion regarding which definition to use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dawber TR, Meadors GF, Moore FE: Epidemiological approaches to heart disease. The Framingham study. Am J Public Health. 1951, 41: 279-286. 10.2105/AJPH.41.3.279.CrossRef Dawber TR, Meadors GF, Moore FE: Epidemiological approaches to heart disease. The Framingham study. Am J Public Health. 1951, 41: 279-286. 10.2105/AJPH.41.3.279.CrossRef
2.
go back to reference Tibblin G: High blood pressure in men aged 50 – a population study of men born in 1913. Acta Med Scand Suppl. 1967, 470: 1-84.PubMed Tibblin G: High blood pressure in men aged 50 – a population study of men born in 1913. Acta Med Scand Suppl. 1967, 470: 1-84.PubMed
3.
go back to reference Larsson B: Obesity. A population study of men, with special reference to development and consequences for the health. PhD thesis. 1978, Göteborg University Larsson B: Obesity. A population study of men, with special reference to development and consequences for the health. PhD thesis. 1978, Göteborg University
4.
go back to reference Welin L, Larsson B, Svärdsudd K, Wilhelmsen L, Tibblin G: Why is the incidence of ischaemic heart disease in Sweden increasing? The study of men born in 1913 and 1923. Lancet. 1983, 14: 1087-1089. 10.1016/S0140-6736(83)91920-7.CrossRef Welin L, Larsson B, Svärdsudd K, Wilhelmsen L, Tibblin G: Why is the incidence of ischaemic heart disease in Sweden increasing? The study of men born in 1913 and 1923. Lancet. 1983, 14: 1087-1089. 10.1016/S0140-6736(83)91920-7.CrossRef
5.
go back to reference Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson AC, Wedel H: Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ. 1990, 300: 634-638.CrossRefPubMedPubMedCentral Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson AC, Wedel H: Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ. 1990, 300: 634-638.CrossRefPubMedPubMedCentral
6.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
7.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 1972, 18: 499-501.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 1972, 18: 499-501.PubMed
8.
go back to reference Welin L, Larsson B, Svärdsudd K, Tibblin B, Tibblin G: Social network and activities in relation to mortality from cardiovascular diseases, cancer and other causes: a 12 year follow up of the Study of Men Born in 1913 and 1923. J Epidemiol Comm Health. 1992, 46: 127-132. 10.1136/jech.46.2.127.CrossRef Welin L, Larsson B, Svärdsudd K, Tibblin B, Tibblin G: Social network and activities in relation to mortality from cardiovascular diseases, cancer and other causes: a 12 year follow up of the Study of Men Born in 1913 and 1923. J Epidemiol Comm Health. 1992, 46: 127-132. 10.1136/jech.46.2.127.CrossRef
9.
go back to reference Welin C, Lappas G, Wilhelmsen L: Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med. 2000, 247: 629-639. 10.1046/j.1365-2796.2000.00694.x.CrossRefPubMed Welin C, Lappas G, Wilhelmsen L: Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med. 2000, 247: 629-639. 10.1046/j.1365-2796.2000.00694.x.CrossRefPubMed
10.
go back to reference SAS system 8.2, SAS Institute Inc., Cary, NC, USA SAS system 8.2, SAS Institute Inc., Cary, NC, USA
11.
go back to reference WHO: Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO consulatation. Part I: Diagnosis and classification of diabetes mellitus. Geneva. 1999 WHO: Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO consulatation. Part I: Diagnosis and classification of diabetes mellitus. Geneva. 1999
12.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
13.
go back to reference Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome – a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome – a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
14.
go back to reference Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G: Risk factors for cardiovascular disease during the period 1985–1995 in Göteborg, Sweden. The GOT-MONICA Project. J Intern Med. 1997, 242: 199-211. 10.1046/j.1365-2796.1997.00163.x.CrossRefPubMed Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G: Risk factors for cardiovascular disease during the period 1985–1995 in Göteborg, Sweden. The GOT-MONICA Project. J Intern Med. 1997, 242: 199-211. 10.1046/j.1365-2796.1997.00163.x.CrossRefPubMed
15.
go back to reference Tibblin G, Welin L, Larsson B, Ljungberg IL, Svärdsudd K: The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. Scand J Soc Med. 1982, 10: 27-32.PubMed Tibblin G, Welin L, Larsson B, Ljungberg IL, Svärdsudd K: The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. Scand J Soc Med. 1982, 10: 27-32.PubMed
16.
go back to reference Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D: Nonparticipants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand. 1987, 221: 243-251.CrossRefPubMed Rosengren A, Wilhelmsen L, Berglund G, Elmfeldt D: Nonparticipants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand. 1987, 221: 243-251.CrossRefPubMed
17.
go back to reference Tunstall-Pedoe H, Ed: MONICA Monograph and Multimedia Sourcebook. 2003, World Health Organisation, Geneva Tunstall-Pedoe H, Ed: MONICA Monograph and Multimedia Sourcebook. 2003, World Health Organisation, Geneva
18.
go back to reference Berg CM, Lissner L, Aires N, Lappas G, Torén K, Wilhelmsen L, Rosengren A, Thelle DS: Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil. 2005, 12: 115-125. 10.1097/00149831-200504000-00005.PubMed Berg CM, Lissner L, Aires N, Lappas G, Torén K, Wilhelmsen L, Rosengren A, Thelle DS: Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil. 2005, 12: 115-125. 10.1097/00149831-200504000-00005.PubMed
19.
go back to reference Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J: Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ. 2005, 331: 551-554. 10.1136/bmj.38555.648623.8F.CrossRefPubMedPubMedCentral Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J: Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ. 2005, 331: 551-554. 10.1136/bmj.38555.648623.8F.CrossRefPubMedPubMedCentral
20.
go back to reference Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007, 7: 220-10.1186/1471-2458-7-220.CrossRefPubMedPubMedCentral Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007, 7: 220-10.1186/1471-2458-7-220.CrossRefPubMedPubMedCentral
21.
go back to reference Rathmann W, Haastert B, Icks A, Giani G, Holle R, Koenig W, Löwel H, Meisinger C: Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care. 2006, 29: 461-10.2337/diacare.29.02.06.dc05-1885.CrossRefPubMed Rathmann W, Haastert B, Icks A, Giani G, Holle R, Koenig W, Löwel H, Meisinger C: Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care. 2006, 29: 461-10.2337/diacare.29.02.06.dc05-1885.CrossRefPubMed
22.
go back to reference Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel K-H: Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary health care: The German metabolic and cardiovascular risk project (GEMCAS). Cardiovascular Diabetology. 2007, 6: 22-10.1186/1475-2840-6-22.CrossRefPubMedPubMedCentral Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel K-H: Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary health care: The German metabolic and cardiovascular risk project (GEMCAS). Cardiovascular Diabetology. 2007, 6: 22-10.1186/1475-2840-6-22.CrossRefPubMedPubMedCentral
23.
go back to reference Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A: Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol. 2007, 117: 204-210. 10.1016/j.ijcard.2006.04.078.CrossRefPubMed Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A: Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol. 2007, 117: 204-210. 10.1016/j.ijcard.2006.04.078.CrossRefPubMed
24.
go back to reference Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-1405. 10.1016/S0140-6736(05)66375-1.CrossRefPubMed Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-1405. 10.1016/S0140-6736(05)66375-1.CrossRefPubMed
25.
go back to reference Harzallah F, Alberti H, Khalifa FB: The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabetic Medicine. 2006, 23: 441-444. 10.1111/j.1464-5491.2006.01866.x.CrossRefPubMed Harzallah F, Alberti H, Khalifa FB: The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabetic Medicine. 2006, 23: 441-444. 10.1111/j.1464-5491.2006.01866.x.CrossRefPubMed
26.
go back to reference Gale EAM: The myth of the metabolic syndrome. Diabetologia. 2005, 48: 1679-1883. 10.1007/s00125-005-1873-5.CrossRefPubMed Gale EAM: The myth of the metabolic syndrome. Diabetologia. 2005, 48: 1679-1883. 10.1007/s00125-005-1873-5.CrossRefPubMed
27.
go back to reference Kahn R, Ferrannini E, Buse J, Stern M: The metabolic syndrome: time for a critical appraisal. Diabetologia. 2005, 48: 1684-1699. 10.1007/s00125-005-1876-2.CrossRefPubMed Kahn R, Ferrannini E, Buse J, Stern M: The metabolic syndrome: time for a critical appraisal. Diabetologia. 2005, 48: 1684-1699. 10.1007/s00125-005-1876-2.CrossRefPubMed
29.
go back to reference Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard C, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371: 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard C, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008, 371: 1927-1935. 10.1016/S0140-6736(08)60602-9.CrossRefPubMed
30.
go back to reference Kahn R: Metabolic syndrome – what is the clinical usefulness?. Lancet. 2008, 371: 1892-1893. 10.1016/S0140-6736(08)60731-X.CrossRefPubMed Kahn R: Metabolic syndrome – what is the clinical usefulness?. Lancet. 2008, 371: 1892-1893. 10.1016/S0140-6736(08)60731-X.CrossRefPubMed
31.
go back to reference Sundström J, Risérus U, Byberg L, Zethelius B, Lithell H, Lind L: Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006, 332: 878-882. 10.1136/bmj.38766.624097.1F.CrossRefPubMedPubMedCentral Sundström J, Risérus U, Byberg L, Zethelius B, Lithell H, Lind L: Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006, 332: 878-882. 10.1136/bmj.38766.624097.1F.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden
Authors
Lennart Welin
Annika Adlerberth
Kenneth Caidahl
Henry Eriksson
Per-Olof Hansson
Saga Johansson
Annika Rosengren
Kurt Svärdsudd
Catharina Welin
Lars Wilhelmsen
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2008
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-8-403

Other articles of this Issue 1/2008

BMC Public Health 1/2008 Go to the issue